Microbot Medical Reports Data from its GLP Pivotal Pre-Clinical Study

Share this
Microbot Medical

Microbot Medical Reports Data from its GLP Pivotal Pre-Clinical Study


  • Microbot Medical concludes its pivotal GLP pre-clinical study in porcine model performed under the US FDA guidelines of planning, controlling, monitoring, and reporting
  • A study conducted by three interventional radiologists on Dec 7, 2023, utilized the LIBERTY Endovascular Robotic Surgical System for 96 robotic navigations. They examined target vessels and surrounding tissue after procedures involving various intravascular catheterization devices controlled by the LIBERTY system
  • The company anticipates IDE submission to the US FDA for the human clinical study based on these results

Ref: Microbot Medical | Image: Microbot Medical

Related News:- Merck KGaA Expand its Collaboration with NKMax to Evaluate the Combination of SNK01 + Erbitux (cetuximab) for Metastatic NSCLC

PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com

Click here to­ read the full press release 

Shivani Chandra

Shivani is a content writer at PharmaShots. She has a keen interest in recent innovations in the life sciences industry. She covers news related to Product approvals, clinical trial results, and updates. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions